기관절개용 제품 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 인구통계학별, 시술별, 최종 용도별, 부문별 예측(2025-2030년)

Tracheostomy Products Market Growth & Trends:

The global tracheostomy products market size is estimated to reach USD 278.7 million by 2030, expanding at a CAGR of 4.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The volume of surgical operations has increased with the rising incidence of chronic respiratory illnesses, such as Cardiovascular Diseases (CVDs), diabetes, respiratory diseases, cancer, or other respiratory injuries. As the number of surgeries conducted worldwide continues to rise, the demand for tracheostomy products is growing at a rapid pace. During the COVID-19 pandemic, the FDA had undertaken steps to ensure prompt access to high-quality medical devices for healthcare providers and patients to respond effectively to a public health emergency.

Therefore, the Emergency Use Authorization (EUA) regulatory strategy aids several enterprises in expanding the availability of respiratory products and accessories. Smiths Medical (U.S.) introduced Portex tracheostomy tubes and kits in January 2020. In COVID-19 patients, tracheostomy is being used to aid with weaning and maximizing healthcare resource usage. Respiratory disorders continue to be more prevalent in economies with middle and low income. According to the WHO, the higher the prevalence of pollution and cigarette usage, the greater the risk of respiratory disorders in the years ahead. This has resulted in the increased need for respiratory accessories, such as tracheostomy products. Asthma affects around 334 million people worldwide and it is the most prevalent chronic illness observed during childhood, impacting around 14% of children.

The lack of experienced professionals and the post-operative risks associated with laparoscopy operations are restricting the market growth. However, several market players are expected to introduce novel, advanced, as well as ergonomically designed upgraded products in the market over the forecast period, creating potential prospects for the market across the globe. North America dominated the global market, in terms of revenue share, in 2021 owing to the rapid development of innovative technologies and therapies for throat cancer and the presence of advanced healthcare infrastructure. However, Asia Pacific is expected to witness the fastest CAGR over the forecast period due to the rising incidence of COPD and other chronic respiratory illnesses.

Tracheostomy Products Market Report Highlights:

• The tracheostomy tubes type segment held the largest revenue share in 2024 as these systems are utilized in treatments for anaphylactic shock, coma, esophageal cancer, laryngectomy, and other disorders
• The percutaneous dilatational tracheostomy techniques segment dominated the market in 2024 as this technique has almost completely replaced surgical tracheostomy in the ICU and is more suitable for severely ill patients requiring prolonged hospital stays
• The adult patients demographics segment led the market in 2024 due to the high prevalence of chronic respiratory disorders among the adult population
• The hospitals & surgery centers end-use segment dominated the market in 2024. The larger capacity of hospitals to procure expensive equipment and the availability of qualified specialists to operate tracheostomy devices are the key factors contributing to the segment growth
• The home care settings end-use segment, on the other hand, is expected to register the fastest CAGR over the forecast period due to the rising number of patients requiring long-term care in home settings

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Technique
  • 1.2.3. Demographics
  • 1.2.4. End Use
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Technique outlook
  • 2.2.3. Demographics outlook
  • 2.2.4. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Tracheostomy Products Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of respiratory disorders
    • 3.2.1.2. Technological advancement
    • 3.2.1.3. Increasing number of minimally invasive procedures
    • 3.2.1.4. Rising healthcare spending
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of surgeries and lack of reimbursement
    • 3.2.2.2. Post-surgical complications
• 3.3. Tracheostomy Products Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Tracheostomy Products Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Tracheostomy Products Market: Type Movement Analysis
• 4.3. Tracheostomy Products Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Tracheostomy Tubes
  • 4.5.1. Tracheostomy Tubes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Ventilation Accessories
  • 4.6.1. Ventilation Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Clean & Care Kits
  • 4.7.1. Clean & Care Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Tracheostomy Products Market: Techniques Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Tracheostomy Products Market: Techniques Movement Analysis
• 5.3. Tracheostomy Products Market by Techniques Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Percutaneous Dilatational Tracheostomy
  • 5.5.1. Percutaneous Dilatational Tracheostomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Surgical Tracheostomy
  • 5.6.1. Surgical Tracheostomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Tracheostomy Products Market: Demographics Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Tracheostomy Products Market: Demographics Movement Analysis
• 6.3. Tracheostomy Products Market by Demographics Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Adult Patients
  • 6.5.1. Adult Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Pediatric/Neonatal Patients
  • 6.6.1. Pediatric/Neonatal Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Tracheostomy Products Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Tracheostomy Products Market: End Use Movement Analysis
• 7.3. Tracheostomy Products Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Hospitals & Surgery Centers
  • 7.5.1. Hospitals & Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Ambulatory Surgical Centers
  • 7.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Home Care Settings
  • 7.7.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Others
  • 7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Tracheostomy Products Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Regional Tracheostomy Products Market Movement Analysis
• 8.3. Tracheostomy Products Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 8.5. North America
  • 8.5.1. North America Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. U.S.
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Competitive Scenario
    • 7.5.2.3 Regulatory Framework
    • 7.5.2.4 Reimbursement scenario
    • 7.5.2.5 U.S. Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Canada
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Competitive Scenario
    • 7.5.3.3 Regulatory Framework
    • 7.5.3.4 Reimbursement scenario
    • 7.5.3.5 Canada Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. Mexico
    • 7.5.4.1 Key Country Dynamics
    • 7.5.4.2 Competitive Scenario
    • 7.5.4.3 Regulatory Framework
    • 7.5.4.4 Reimbursement scenario
    • 7.5.4.5 Mexico Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. UK
    • 8.6.2.1 Key Country Dynamics
    • 8.6.2.2 Competitive Scenario
    • 8.6.2.3 Regulatory Framework
    • 8.6.2.4 Reimbursement scenario
    • 8.6.2.5 UK Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1 Key Country Dynamics
    • 8.6.3.2 Competitive Scenario
    • 8.6.3.3 Regulatory Framework
    • 8.6.3.4 Reimbursement scenario
    • 8.6.3.5 Germany Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. France
    • 8.6.4.1 Key Country Dynamics
    • 8.6.4.2 Competitive Scenario
    • 8.6.4.3 Regulatory Framework
    • 8.6.4.4 Reimbursement scenario
    • 8.6.4.5 France Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1 Key Country Dynamics
    • 8.6.5.2 Competitive Scenario
    • 8.6.5.3 Regulatory Framework
    • 8.6.5.4 Reimbursement scenario
    • 8.6.5.5 Italy Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1 Key Country Dynamics
    • 8.6.6.2 Competitive Scenario
    • 8.6.6.3 Regulatory Framework
    • 8.6.6.4 Reimbursement scenario
    • 8.6.6.5 Spain Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Denmark
    • 8.6.7.1 Key Country Dynamics
    • 8.6.7.2 Competitive Scenario
    • 8.6.7.3 Regulatory Framework
    • 8.6.7.4 Reimbursement scenario
    • 8.6.7.5 Denmark Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1 Key Country Dynamics
    • 8.6.8.2 Competitive Scenario
    • 8.6.8.3 Regulatory Framework
    • 8.6.8.4 Reimbursement scenario
    • 8.6.8.5 Sweden Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.9. Norway
    • 8.6.9.1 Key Country Dynamics
    • 8.6.9.2 Competitive Scenario
    • 8.6.9.3 Regulatory Framework
    • 8.6.9.4 Reimbursement scenario
    • 8.6.9.5 Norway Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Asia Pacific Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Japan
    • 8.7.2.1 Key Country Dynamics
    • 8.7.2.2 Competitive Scenario
    • 8.7.2.3 Regulatory Framework
    • 8.7.2.4 Reimbursement scenario
    • 8.7.2.5 Japan Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. China
    • 8.7.3.1 Key Country Dynamics
    • 8.7.3.2 Competitive Scenario
    • 8.7.3.3 Regulatory Framework
    • 8.7.3.4 Reimbursement scenario
    • 8.7.3.5 China Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. India
    • 8.7.4.1 Key Country Dynamics
    • 8.7.4.2 Competitive Scenario
    • 8.7.4.3 Regulatory Framework
    • 8.7.4.4 Reimbursement scenario
    • 8.7.4.5 India Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1 Key Country Dynamics
    • 8.7.5.2 Competitive Scenario
    • 8.7.5.3 Regulatory Framework
    • 8.7.5.4 Reimbursement scenario
    • 8.7.5.5 South Korea Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.7.6.1 Key Country Dynamics
    • 8.7.6.2 Competitive Scenario
    • 8.7.6.3 Regulatory Framework
    • 8.7.6.4 Reimbursement scenario
    • 8.7.6.5 Australia Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.7. Thailand
    • 8.7.7.1 Key Country Dynamics
    • 8.7.7.2 Competitive Scenario
    • 8.7.7.3 Regulatory Framework
    • 8.7.7.4 Reimbursement scenario
    • 8.7.7.5 Thailand Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Latin America Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. Brazil
    • 8.8.2.1 Key Country Dynamics
    • 8.8.2.2 Competitive Scenario
    • 8.8.2.3 Regulatory Framework
    • 8.8.2.4 Reimbursement scenario
    • 8.8.2.5 Brazil Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.26. Argentina
    • 8.8.3.1 Key Country Dynamics
    • 8.8.3.2 Competitive Scenario
    • 8.8.3.3 Regulatory Framework
    • 8.8.3.4 Reimbursement scenario
    • 8.8.3.5 Argentina Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.9. Middle East & Africa
  • 8.9.1. Middle East & Africa Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.2. South Africa
    • 8.9.2.1 Key Country Dynamics
    • 8.9.2.2 Competitive Scenario
    • 8.9.2.3 Regulatory Framework
    • 8.9.2.4 Reimbursement scenario
    • 8.9.2.5 South Africa Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.3. Saudi Arabia
    • 8.9.3.1 Key Country Dynamics
    • 8.9.3.2 Competitive Scenario
    • 8.9.3.3 Regulatory Framework
    • 8.9.3.4 Reimbursement scenario
    • 8.9.3.5 Saudi Arabia Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.4. UAE
    • 8.9.4.1 Key Country Dynamics
    • 8.9.4.2 Competitive Scenario
    • 8.9.4.3 Regulatory Framework
    • 8.9.4.4 Reimbursement scenario
    • 8.9.4.5 UAE Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.5. Kuwait
    • 8.9.5.1 Key Country Dynamics
    • 8.9.5.2 Competitive Scenario
    • 8.9.5.3 Regulatory Framework
    • 8.9.5.4 Reimbursement scenario
    • 8.9.5.5 Kuwait Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Pulmodyne, Inc.
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. Smiths Group plc
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Medtronic
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. TRACOE Medical GmbH
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Teleflex, Incorporated.
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Cook Group
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Convatec Group PLC
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Boston Medical Products Inc.
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Fisher & Paykel Healthcare Limited.
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. ANGIPLAST PRIVATE LIMITED.
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives